Stanford University
Showing 121-130 of 2,438 Results
-
Elahe Bashiri
Affiliate, Institute for Human-Centered Artificial Intelligence (HAI)
BioElahe Bashiri is a researcher at Stanford’s Institute for Human-Centered Artificial Intelligence (HAI), where she studies interdisciplinary collaboration between AI researchers and domain experts. Her work focuses on designing human-centered AI tools that align with clinical workflows, foster trust, and support the ethical integration of AI in real-world healthcare settings.
-
Michael Bassik
Associate Professor of Genetics
Current Research and Scholarly InterestsWe are an interdisciplinary lab focused on two major areas:(1) we seek to understand mechanisms of cancer growth and drug resistance in order to find new therapeutic targets(2) we study mechanisms by which macrophages and other cells take up diverse materials by endocytosis and phagocytosis; these substrates range from bacteria, viruses, and cancer cells to drugs and protein toxins. To accomplish these goals, we develop and use new technologies for high-throughput functional genomics.
-
Glaivy Batsuli, MD
Associate Professor of Pediatrics (Hematology/Oncology)
Current Research and Scholarly InterestsHemophilia is a rare inherited X-linked bleeding disorder characterized by the deficiency of blood clotting proteins factor VIII or factor IX. These individuals are at risk for spontaneous bleeds and trauma or surgery-induced bleeding. There have been remarkable advancements in the management of hemophilia to prevent these bleeding episodes and improve quality of life. However, the presence of neutralizing antibodies, called inhibitors, still dictates access to novel therapies such as factor replacement for bleed management and now FDA-approved gene therapies. The Batsuli Lab is focused on elucidating mechanisms of the immune response to blood coagulation proteins in bleeding disorders in order to develop strategies and therapeutics for inhibitor prevention and tolerance induction.
Dr. Batsuli's clinical research interests also include clinical trial participation for novel therapeutics & interventions in bleeding disorders such as hemophilia and von Willebrand disease in addition to coagulation issues & outcomes in ultra-rare bleeding disorders and sickle cell disease. -
Marley Bauce
Managing Director, Geballe Laboratory for Advanced Materials
BioMarley Bauce joined Stanford in January 2023 as the Managing Director or the Geballe Laboratory for Advanced Materials (GLAM), one of 15 independent and transdisciplinary labs within the Office of the Vice Provost and Dean of Research. In this role, he provides managerial, financial, facilities, strategic planning, and research administrative support for GLAM’s faculty, trainees, and administrative staff, while optimizing the vibrancy, interconnectivity, and safety of materials research across the university.
Prior to joining Stanford, Marley spent a decade at Columbia University, first as the Director of Research Development within the Office of the Executive Vice President for Research, then most recently as the inaugural Associate Dean for Research at the Climate School, where he created and led an 11-person Office of Research spanning compliance, grants administration, federal affairs, and strategic initiatives. Over his tenure at Columbia, he directly supported and wrote “center grant” proposals awarded $100M+ in federal funding.
Marley has an MPA in Management & Finance from Columbia University, an MA in Environmental Studies from NYU, and a BA in Philosophy from Hampshire College. -
Fiona Baumer
Assistant Professor of Neurology (Pediatric Neurology)
Current Research and Scholarly InterestsCauses of Disturbed Cognition in Pediatric Epilepsy
-
Mohsen Bayati
Carl and Marilynn Thoma Professor in the Graduate School of Business and Professor, by courtesy, of Electrical Engineering and of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly Interests1) Healthcare management: I am interested in improving healthcare delivery using data-driven modeling and decision-making.
2) Network models and message-passing algorithms: I work on graphical modeling ideas motivated from statistical physics and their applications in statistical inference.
3) Personalized decision-making: I work on machine learning and statistical challenges of personalized decision-making. The problems that I have worked on are primarily motivated by healthcare applications. -
Tina Baykaner
Assistant Professor of Medicine (Cardiovascular Medicine)
BioTina Baykaner is an Assistant Professor in the Department of Internal Medicine, Division of Cardiovascular Medicine and Electrophysiology. Following internal medicine residency, cardiovascular medicine and advanced heart failure fellowship trainings at University of California, San Diego and electrophysiology fellowship at Stanford University, Dr. Baykaner joined Stanford University faculty in 2018. She has published over 200 papers, book chapters and abstracts including over 100 original peer-reviewed articles, and delivered over 100 invited presentations in national and international meetings. She serves as associate editor, section editor and editorial board member of four electrophysiology journals and served in guideline writing committees.
Dr. Baykaner’s current research interests include outcomes research, epidemiology and mechanisms of rhythm disorders. She is currently funded by the National Institutes of Health to study patient related outcomes regarding atrial fibrillation (AF) ablation. She received prior research funding from American Heart Association and Heart Rhythm Society. Dr. Baykaner's clinical practice focuses on ablation of atrial and ventricular arrhythmias, SVTs, inappropriate sinus tachycardia management, device implantation and device extraction.
Dr. Baykaner is an active member of American Heart Association (AHA), American College of Cardiology (ACC), Heart Rhythm Society (HRS) and European Society of Cardiology (ESC). She serves as an elected member of the Digital Health Committee for HRS, and previously served as an elected member of the HRS Communications Committee and ACC Task Force ICD research committee.
